The DOI matches its Crossref record; 800 of the 800 references it cites were found in a registry or an index.
Pulmonary Arterial Hypertension
Abstract
ost practicing cardiologists see patients with pulmo- nary hypertension (PH) on a regular basis.Although this is most commonly in the form of pulmonary venous hypertension related to elevated left heart pressures, the explosion in knowledge of and treatment for pulmonary arterial hypertension (PAH) over the past decade obligates cardiologists to be more cognizant of this disorder.In this review, we will discuss the pathobiology, classification, diagnosis, and treatment of PAH in adults.The term PAH in this context refers specifically to a pulmonary hypertensive state limited predominantly to the arterial component of the pulmonary vasculature and constitutes one of the main classifications of clinical PH diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 601–800 of 800
Primary Pulmonary Hypertension Associated With the Use of Fenfluramine Derivatives
Simonneau, G., Fartoukh, M. S., Sitbon, O., Humbert, M. J. C., Jagot, J.-L., & Hervé, P. (1998) · CHEST Journal · doi:10.1378/chest.114.3_supplement.195s · Cited by 108
Hayag-Barin, J. E., Smith, R. E., & Tucker, F. C. (1998) · American Journal of Hematology · doi:10.1002/(sici)1096-8652(199801)57:1<82::aid-ajh15>3.0.co;2-b · Cited by 108
Pathobiology of pulmonary arterial hypertension
Eddahibi, S., Morrell, N. W., d’Ortho, M., Naeije, R., & Adnot, S. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.00081302 · Cited by 107
Management of Cytomegalovirus Infection and Disease after Solid‐Organ Transplantation
van der Bij, W., & Speich, R. (2001) · Clinical Infectious Diseases · doi:10.1086/320902 · Cited by 107
Effects of Epoprostenol on Right Ventricular Hypertrophy and Dilatation in Pulmonary Hypertension
Roeleveld, R. J., Noordegraaf, A. V., Marcus, J. T., Bronzwaer, J. G. F., Marques, K. M., Postmus, P. E., & Boonstra, A. (2004) · CHEST Journal · doi:10.1378/chest.125.2.572 · Cited by 107
Kaluski, E., Cotter, G., Leitman, M., Milo‐Cotter, O., Krakover, R., Kobrin, I., Moriconi, T., Rainisio, M., Caspi, A., Reizin, L., et al. (2007) · Cardiology · doi:10.1159/000107791 · Cited by 106
Surgical treatment of pulmonary artery sarcoma
Mayer, E., Kriegsmann, J., Gaumann, A. K. A., Kauczor, H., Dahm, M., Hake, U., Schmid, F. X., & Oelert, H. (2001) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1067/mtc.2001.111423 · Cited by 106
Haemodynamic and hormonal effects of adrenomedullin in patients with pulmonary hypertension
Nagaya, N., Nishikimi, T., Uematsu, M., Satoh, T., Oya, H., Kyotani, S., Sakamaki, F., Ueno, K., Nakanishi, N., Miyatake, K., et al. (2000) · Heart · doi:10.1136/heart.84.6.653 · Cited by 106
Evgenov, O. V., Ichinose, F., Evgenov, N. V., Gnoth, M. J., Falkowski, G. E., Chang, Y., Bloch, K. D., & Zapol, W. M. (2004) · Circulation · doi:10.1161/01.cir.0000144469.01521.8a · Cited by 106
Medical Therapies for Chronic Thromboembolic Pulmonary Hypertension: An Evolving Treatment Paradigm
Bresser, P., Pepke-Zaba, J., Jaïs, X., Humbert, M. J. C., & Hoeper, M. M. (2006) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200605-115lr · Cited by 105
Nocturnal Hypoxemia Is Common in Primary Pulmonary Hypertension
Rafanan, A. L., Golish, J. A., Dinner, D. S., Hague, L. K., & Arroliga, A. C. (2001) · CHEST Journal · doi:10.1378/chest.120.3.894 · Cited by 105
A Combination of Oral Sildenafil and Beraprost Ameliorates Pulmonary Hypertension in Rats
Itoh, T., Nagaya, N., Fujii, T., et al. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200303-346oc · Cited by 104
Regression of extreme pulmonary hypertension after mitral valve surgery
Zener, J. C., Hancock, E. W., Shumway, N. E., & Harrison, D. C. (1972) · The American Journal of Cardiology · doi:10.1016/0002-9149(72)90005-7 · Cited by 104
Stojnić, B., Brecker, S. J., Xiao, H., Helmy, S., Mbaissouroum, M., & Gibson, D. G. (1992) · Heart · doi:10.1136/hrt.68.7.16 · Cited by 104
Anterior Ischemic Optic Neuropathy Associated With Viagra
Cunningham, A. V., & Smith, K. H. (2001) · Journal of Neuro-Ophthalmology · doi:10.1097/00041327-200103000-00006 · Cited by 103
Boerrigter, G., Costello‐Boerrigter, L. C., Cataliotti, A., Tsuruda, T., Harty, G. J., Lapp, H., Stasch, J., & Burnett, J. C. J. (2003) · Circulation · doi:10.1161/01.cir.0000055737.15443.f8 · Cited by 103
Targeted therapy by disablingcrossroadsignaling networks: the survivin paradigm
Altieri, D. C. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0436 · Cited by 103
Pulmonary Complications of Sickle Cell Anemia
Minter, K. R., & Gladwin, M. T. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.11.2104101 · Cited by 102
Peacock, A., Simonneau, G., & Rubin, L. (2006) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200605-114lr · Cited by 101
Elastase and the Pathobiology of Unexplained Pulmonary Hypertension
Rabinovitch, M. (1998) · CHEST Journal · doi:10.1378/chest.114.3_supplement.213s · Cited by 100
High prevalence of hypothyroidism in patients with primary pulmonary hypertension.
Curnock, A. L., Dweik, R., Higgins, B., Saadi, H., & Arroliga, A. (1999) · American Journal of the Medical Sciences · doi:10.1016/s0002-9629(15)40640-8 · Cited by 100
Single- Versus Double-Lung Transplantation For Pulmonary Hypertension
Gammie, J. S., Keenan, R. J., Pham, S. M., McGrath, M., Hattler, B. G. J., Khoshbin, E., & Griffith, B. P. (1998) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(98)70284-3 · Cited by 100
Increased plasma levels of adrenomedullin in patients with pulmonary hypertension
Kakishita, M., Nishikimi, T., Okano, Y., Satoh, T., Kyotani, S., Nagaya, N., Fukushima, K., Nakanishi, N., Takishita, S., Miyata, A., et al. (1999) · Clinical Science · doi:10.1042/cs0960033 · Cited by 99
Zhu, L., Wigle, D. A., Hinek, A., Kobayashi, J., Ye, C., Zuker, M., Dodo, H., Keeley, F. W., & Rabinovitch, M. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117432 · Cited by 99
DeBusk, R. F., Pepine, C. J., Glasser, D. B., Shpilsky, A., Deriesthal, H., & Sweeney, M. L. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2003.09.030 · Cited by 99
Girgis, R. E., Frost, A., Hill, N. S., Horn, E. M., Langleben, D., McLaughlin, V. V., Oudiz, R. J., Robbins, I., Seibold, J. R., Shapiro, S., et al. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.069609 · Cited by 99
Self-citationPenning, S., Robinson, K. D., Major, C. A., et al. (2001) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2001.114857 · Cited by 98
Involvement of Hypoxia-Inducible Factor 1 in Pulmonary Pathophysiology
Semenza, G. L. (2005) · CHEST Journal · doi:10.1378/chest.128.6_suppl.592s · Cited by 98
Kasimir, M. (2004) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/j.ejcts.2004.05.057 · Cited by 98
Stimulant-Induced Pulmonary Toxicity
Albertson, T. E., Walby, W. F., & Derlet, R. W. (1995) · CHEST Journal · doi:10.1378/chest.108.4.1140 · Cited by 97
Single Lung Transplantation for Primary Pulmonary Hypertension
Levine, S. M., Gibbons, W. J., Bryan, C. L., Walling, A. D., Brown, R. W., Bailey, S. R., Cronin, T., Calhoon, J. P., Trinkle, J. K., & Jenkinson, S. G. (1990) · CHEST Journal · doi:10.1378/chest.98.5.1107 · Cited by 97
Voelkel, N. F., Cool, C. D., Taraceviene-Stewart, L., Geraci, M. W., Yeager, M. E., Bull, T. M., Kasper, M. E., & Tuder, R. M. (2002) · Critical Care Medicine · doi:10.1097/00003246-200205001-00013 · Cited by 96
Primary pulmonary hypertension.
Hatano, K. (1975) · Medical Entomology and Zoology · Cited by 95
Assessment of Operability in Chronic Thromboembolic Pulmonary Hypertension
Kim, N. H. (2006) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200605-106lr · Cited by 94
Sildenafil (Viagra) Associated Anterior Ischemic Optic Neuropathy
Egan, R., & Pomeranz, H. D. (2000) · Archives of Ophthalmology · doi:10.1001/archopht.118.2.291 · Cited by 93
Botney, M. D. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.159.2.9805075 · Cited by 93
Effects of Dipyridamole and Inhaled Nitric Oxide in Pediatric Patients with Pulmonary Hypertension
Ziegler, J. W., Ivy, D. D., Wiggins, J. W., Kinsella, J. P., Clarke, W. R., & Abman, S. H. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.158.5.9710117 · Cited by 93
Angiogenesis in Chronic Lung Disease
Voelkel, N. F., Douglas, I. S., & Nicolls, M. R. (2007) · CHEST Journal · doi:10.1378/chest.06-2453 · Cited by 93
The new clinical trials on pharmacological treatment in pulmonary arterial hypertension
Galiè, N., Mañes, A., & Branzi, A. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.05542002 · Cited by 93
Rare diseases bullet 5: Primary pulmonary hypertension
Peacock, A. (1999) · Thorax · doi:10.1136/thx.54.12.1107 · Cited by 92
Saji, T., Ozawa, Y., Ishikita, T., et al. (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(96)90408-7 · Cited by 92
PATHOBIOLOGY OF PULMONARY HYPERTENSION
Rabinovitch, M. (2001) · Clinics in Chest Medicine · doi:10.1016/s0272-5231(05)70282-3 · Cited by 92
Gore, J., & Silver, R. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.034488 · Cited by 91
Augmented K+currents and mitochondrial membrane depolarization in pulmonary artery myocyte apoptosis
Krick, S., Platoshyn, O., McDaniel, S. S., Rubin, L. J., & Yuan, J. X. ‐. (2001) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2001.281.4.l887 · Cited by 91
Prolonged pulmonary vasodilator action of inhaled nitric oxide by Zaprinast in awake lambs
Ichinose, F., Adrie, C., Hurford, W. E., & Zapol, W. M. (1995) · Journal of Applied Physiology · doi:10.1152/jappl.1995.78.4.1288 · Cited by 90
Cyclic nucleotide phosphodiesterases in pancreatic islets
Pyne, N. J., & Furman, B. L. (2003) · Diabetologia · doi:10.1007/s00125-003-1176-7 · Cited by 90
Lung transplantation for primary and secondary pulmonary hypertension
Conte, J. V., Borja, M. J., Patel, C. B., Yang, S., Jhaveri, R. M., & Orens, J. B. (2001) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(01)03081-8 · Cited by 90
Gopal, V. K., Francis, S. H., & Corbin, J. D. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.02233.x · Cited by 89
Microvascular Regeneration in Established Pulmonary Hypertension by Angiogenic Gene Transfer
Zhao, Y. D., Courtman, D. W., Ng, D. S., Robb, M. J., Deng, Y., Trogadis, J. E., Han, R. N. N., & Stewart, D. J. (2006) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2005-0115oc · Cited by 89
Endogenous Endothelin-1 Is Required for Cardiomyocyte Survival In Vivo
Zhao, X.-S., Pan, W., Bekeredjian, R., & Shohet, R. V. (2006) · Circulation · doi:10.1161/circulationaha.105.577288 · Cited by 88
Temporal trends and drug exposures in pulmonary hypertension: An American experience
Walker, A. M., Langleben, D., Korelitz, J., Rich, S., Rubin, L. J., Strom, B. L., Gonin, R., Keast, S., Badesch, D. B., Barst, R. J., et al. (2006) · American Heart Journal · doi:10.1016/j.ahj.2006.02.020 · Cited by 88
Self-citationDeng, Z., Haghighi, F. G., HELLEBY, L., VANTERPOOL, K., Horn, E. M., Barst, R. J., Hodge, S. E., Morse, J. H., & Knowles, J. A. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.3.9906051 · Cited by 87
The Current Treatment of Pulmonary Arterial Hypertension
Rich, S. (2006) · CHEST Journal · doi:10.1378/chest.130.4.1198 · Cited by 87
Effect of sildenafil on blood pressure and arterial wave reflection in treated hypertensive men
Mahmud, A., Hennessy, M., & Feely, J. (2001) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001244 · Cited by 86
Seyfarth, H., Pankau, H., Hammerschmidt, S., Schauer, J., Wirtz, H. R. W., & Winkler, J. (2005) · CHEST Journal · doi:10.1378/chest.128.2.709 · Cited by 86
Yamamoto, K. (2000) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00101-2 · Cited by 86
Oka, M., Karoor, V., Homma, N., Nagaoka, T., Sakao, E., Golembeski, S. M., Limbird, J. N., IMAMURA, M., Gebb, S. A., & Fagan, K. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.01.021 · Cited by 86
Webster, L., Michelakis, E. D., Davis, T. M. A., & Archer, S. L. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.5.514 · Cited by 86
NO Contest: Nitrite Versus S -Nitroso-Hemoglobin
Gladwin, M. T., & Schechter, A. N. (2004) · Circulation Research · doi:10.1161/01.res.0000126697.64381.37 · Cited by 85
Lapa, M. S., Ferreira, E. V. M., Jardim, C., Martins, B. D. C. D. S., Arakaki, J. S. O., & Souza, R. (2006) · Revista da Associação Médica Brasileira · doi:10.1590/s0104-42302006000300012 · Cited by 84
Wort, S. J., Woods, M., Warner, T. D., Evans, T. W., & Mitchell, J. A. (2001) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.25.1.4331 · Cited by 83
Reoperative pulmonary thromboendarterectomy
Mo, M., Kapelanski, D. P., Mitruka, S. N., Auger, W. R., Fedullo, P. F., Channick, R. N., Kerr, K. M., Archibald, C. J., & Jamieson, S. W. (1999) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(99)01043-7 · Cited by 83
Hyperthyroidism and pulmonary hypertension
Marvisi, M., Brianti, M., Marani, G., Borrello, P. D., Bortesi, M., & GUARIGLIA, A. (2002) · Respiratory Medicine · doi:10.1053/rmed.2001.1260 · Cited by 83
Risk Factors for Chronic Thromboembolic Pulmonary Hypertension
Lang, I. M., & Kerr, K. M. (2006) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200605-108lr · Cited by 83
Langleben, D., Christman, B. W., Barst, R. J., et al. (2002) · American Heart Journal · doi:10.1067/mhj.2002.121806 · Cited by 82
Dynamic changes of gene expression in hypoxia-induced right ventricular hypertrophy
Sharma, S., Taegtmeyer, H., Adrogue, J. V., Razeghi, P., Sen, S., Ngumbela, K. C., & Essop, M. F. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00916.2003 · Cited by 81
Mano, Y., Usui, T., & Kamimura, H. (2006) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.527 · Cited by 81
Ca/CaM-Stimulated and cGMP-Specific Phosphodiesterases in Vascular and Non-Vascular Tissues
Ahn, H. S., Foster, M., Cable, M., Pitts, B. J. R., & Sybertz, E. J. (1991) · Advances in experimental medicine and biology · doi:10.1007/978-1-4684-6015-5_15 · Cited by 81
Conte, J. V., Gaine, S., Orens, J. B., Harris, T., & Rubin, L. J. (1998) · PubMed · Cited by 81
Altered K+current of ventricular myocytes in rats with chronic myocardial infarction
Rozanski, G. J., Zhi, X., Zhang, K., et al. (1998) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1998.274.1.h259 · Cited by 80
Hypoxic pulmonary vasoconstriction
Dumas, J., Bardou, M., Goirand, F., & Dumas, M. (1999) · General Pharmacology The Vascular System · doi:10.1016/s0306-3623(99)00026-9 · Cited by 80
Hypoxic pulmonary vasoconstriction: role of ion channels
Mauban, J. R. H., Remillard, C. V., & Yuan, J. X.-J. (2004) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00732.2004 · Cited by 80
Trell, E., Johansson, B. W., Linell, F., & Ripa, J. (1972) · The American Journal of Medicine · doi:10.1016/0002-9343(72)90115-5 · Cited by 79
de Cleva, R., Herman, P., Pugliese, V., Zilberstein, B., Saad, W. A., Rodrigues, J. J. G., & Laudanna, A. A. (2003) · PubMed · Cited by 78
Harada, N., Himeno, A., Shigematsu, K., Sumikawa, K., & Niwa, M. (2002) · Cellular and Molecular Neurobiology · doi:10.1023/a:1019822107048 · Cited by 78
McMurtry, M. S., Bonnet, S., Michelakis, E. D., Bonnet, S. B., Haromy, A., & Archer, S. L. (2007) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00310.2006 · Cited by 78
Is the serotonin transporter involved in the pathogenesis of pulmonary hypertension?
Eddahibi, S., Raffestin, B., Hamon, M., & Adnot, S. (2002) · Journal of Laboratory and Clinical Medicine · doi:10.1067/mlc.2002.122181 · Cited by 76
Robbins, I. M., Christman, B. W., Newman, J. H., Matlock, R. J., & Loyd, J. E. (1998) · CHEST Journal · doi:10.1378/chest.114.5.1269 · Cited by 76
Ohlstein, E. H., & Douglas, S. A. (1993) · Drug Development Research · doi:10.1002/ddr.430290207 · Cited by 76
Fox, K., Thadani, U., Ma, P. T. S., Nash, S. D., Keating, Z., Czorniak, M. A., Gillies, H., & Keltai, M. (2003) · European Heart Journal · doi:10.1016/j.ehj.2003.09.021 · Cited by 76
Bárbaro, G., Lucchini, A., Pellicelli, A. M., Grisorio, B., Giancaspro, G., & Barbarini, G. (2006) · Heart · doi:10.1136/hrt.2005.076794 · Cited by 75
Tilton, R. G., Munsch, C. L., Sherwood, S. J., Chen, S., Chen, Y. F., Wu, C., Blok, N., Dixon, R. A. F., & Brock, T. A. (2000) · Pulmonary Pharmacology & Therapeutics · doi:10.1006/pupt.2000.0237 · Cited by 75
Ward, M. R., Stewart, D. J., & Kutryk, M. J. B. (2007) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.21302 · Cited by 74
Comparison of reported and expected deaths in sildenafil (Viagra) users
Wysowski, D. K., Farinas, E., & Swartz, L. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02342-1 · Cited by 74
Bosentan in inoperable chronic thromboembolic pulmonary hypertension
Hughes, R. J. (2005) · Thorax · doi:10.1136/thx.2005.046961 · Cited by 74
Janecki, A. J., Janecki, M., Akhter, S., & Donowitz, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.11.8133 · Cited by 73
Efficacy and safety of sildenafil citrate in men with erectile dysfunction and chronic heart failure
Katz, S. D., Parker, J. D., Glasser, D. B., Bank, A. J., Sherman, N., Wang, H., & Sweeney, M. L. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.08.060 · Cited by 73
Protein Targets of Monocrotaline Pyrrole in Pulmonary Artery Endothelial Cells
Lamé, M. W., Jones, A. D., Wilson, D. W., Dunston, S. K., & Segall, H. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001372200 · Cited by 73
Pulmonary Hypertension Secondary to Thrombocytosis in a Patient with Myeloid Metaplasia
Marvin, K. S., & Spellberg, R. D. (1993) · CHEST Journal · doi:10.1378/chest.103.2.642 · Cited by 73
Pulmonary hypertension in collagen vascular disease: Table 1—
Hoeper, M. M. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.01512001 · Cited by 73
Sildenafil citrate use and the incidence of nonarteritic anterior ischemic optic neuropathy
Gorkin, L., Hvidsten, K., Sobel, R. E., & Siegel, R. L. (2006) · International Journal of Clinical Practice · doi:10.1111/j.1368-5031.2006.00904.x · Cited by 72
Guilpain, P., Montani, D., Damaj, G. L., Achouh, L., Lefrère, F., Pavec, J. L., Marfaing‐Koka, A., Dartevelle, P., Simonneau, G., Humbert, M. J. C., et al. (2007) · Respiration · doi:10.1159/000112822 · Cited by 71
MEDIATORS, CYTOKINES, AND GROWTH FACTORS IN LIVER-LUNG INTERACTIONS
Panos, R. J., & Baker, S. K. (1996) · Clinics in Chest Medicine · doi:10.1016/s0272-5231(05)70305-1 · Cited by 71
Understanding, assessing and treating Raynaudʼs phenomenon
Boin, F., & Wigley, F. M. (2005) · Current Opinion in Internal Medicine · doi:10.1097/01.bor.0000179944.35400.6e · Cited by 70
Hypothyroidism and Primary Pulmonary Hypertension: An Autoimmune Pathogenetic Link?
Badesch, D. B., Wynne, K. M., Bonvallet, S., Voelkel, N. F., Ridgway, E. C., & Groves, B. M. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-1-199307010-00008 · Cited by 70
(2000) · doi:10.1002/1096-9896(2000)9999:9999 · Cited by 70
Jaïs, X., Till, S. J., Cynober, T., Ioos, V., Garcia, G., Tchernia, G., Dartevelle, P., Simonneau, G., Delaunay, J., & Humbert, M. J. C. (2003) · Hemoglobin · doi:10.1081/hem-120023377 · Cited by 70
Selective serotonin reuptake inhibitor use and outcomes in pulmonary arterial hypertension
Kawut, S. M., Horn, E. M., Berekashvili, K. K., Lederer, D. J., Widlitz, A. C., Rosenzweig, E. B., & Barst, R. J. (2006) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2006.01.001 · Cited by 69
Pulmonary arterial hypertension in congenital heart disease
Granton, J. T., & Rabinovitch, M. (2002) · Cardiology Clinics · doi:10.1016/s0733-8651(02)00017-6 · Cited by 69
Rubin, L. J., Hoeper, M. M., Klepetko, W., Galiè, N., Lang, I. M., & Simonneau, G. (2006) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200605-111lr · Cited by 68
Ion channels in pulmonary arterial hypertension
Mandegar, M., Remillard, C. V., & Yuan, J. X. ‐. (2002) · Progress in Cardiovascular Diseases · doi:10.1053/pcad.2002.127491 · Cited by 68
ATRIAL SEPTAL DEFECT WITH PULMONARY HYPERTENSION
Besterman, E. M. M. (1961) · Heart · doi:10.1136/hrt.23.5.587 · Cited by 68
The Role of the NO Axis and its Therapeutic Implications in Pulmonary Arterial Hypertension
Michelakis, E. D. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/1-4020-7960-5_19 · Cited by 67
Bone morphogenetic proteins, genetics and the pathophysiology of primary pulmonary hypertension
deCaestecker, M. P., & Meyrick, B. O. (2001) · Respiratory Research · doi:10.1186/rr57 · Cited by 66
Ramalingam, P., Rybicki, L. A., Smith, M. D., et al. (2002) · Modern Pathology · doi:10.1038/modpathol.3880581 · Cited by 66
Primary Pulmonary Hypertension In Israel
Appelbaum, L., Yigla, M., Bendayan, D., Reichart, N., Fink, G., Priel, I. E., Schwartz, Y., Richman, P. S., Picard, E., Goldman, S., et al. (2001) · CHEST Journal · doi:10.1378/chest.119.6.1801 · Cited by 66
Molecular effects of loss of BMPR2 signaling in smooth muscle in a transgenic mouse model of PAH
Tada, Y., Majka, S. M., Carr, M., Harral, J. W., Crona, D. J., Kuriyama, T., & West, J. D. (2007) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00305.2006 · Cited by 66
Reperfusion injury in single-lung transplant recipients with pulmonary hypertension and emphysema.
Boujoukos, A. J., Martich, G. D., Vega, J. D., Keenan, R. J., & GRIFFITH, B. P. (1997) · PubMed · Cited by 65
Pulmonary hypertension: pathophysiology as a basis for clinical decision making
Rabinovitch, M. (1999) · The Journal of Heart and Lung Transplantation · doi:10.1016/s1053-2498(99)00015-7 · Cited by 65
van Giersbergen, P. L. M., Treiber, A., Clozel, M., Bodin, F., & Dingemanse, J. (2002) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2002.122473 · Cited by 65
Sitaxsentan Treatment for Patients With Pulmonary Arterial Hypertension Discontinuing Bosentan
Benza, R. L., Mehta, S., KEOGH, A. M., Lawrence, E. C., Oudiz, R. J., & Barst, R. J. (2007) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2006.10.019 · Cited by 65
Endothelin-1 and serotonin: Mediators of primary and secondary pulmonary hypertension?
MacLean, M. R. (1999) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(99)90114-2 · Cited by 64
Pulmonary arterial hypertension: New insights and new hope
Martin, K. B., Klinger, J. R., & Rounds, S. (2006) · Respirology · doi:10.1111/j.1440-1843.2006.00778.x · Cited by 64
Genetics of pulmonary hypertension: from bench to bedside
Humbert, M. J. C., & Trembath, R. C. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.02702002 · Cited by 64
Raeside, D., Smith, A. J., Brown, A., et al. (2000) · European Respiratory Journal · doi:10.1034/j.1399-3003.2000.16b16.x · Cited by 64
Proceedings of the pathological Society of Great Britain and Ireland, 9th, 10th and 11th July 1970
Barer, G. R., Cook, C., Clegg, E. J., & Shaw, J. W. (1970) · The Journal of Pathology · doi:10.1002/path.1711010408 · Cited by 64
Mares, P., Gilbert, T. B., Tschernko, E., Hiesmayr, M., Muhm, M., Herneth, A. M., Taghavi, S., Klepetko, W., Lang, I. M., & HAIDER, W. (2000) · Anesthesia & Analgesia · doi:10.1097/00000539-200002000-00006 · Cited by 63
Effects of Statins on Endothelium and Endothelial Progenitor Cell Recruitment
Walter, D. H., Dimmeler, S., & Zeiher, A. M. (2004) · Seminars in Vascular Medicine · doi:10.1055/s-2004-869595 · Cited by 63
Bloch, W., Klotz, T., Sedlaczek, P., Zumbe, J., Engelmann, U. H., & Addicks, K. (1998) · Urological Research · doi:10.1007/s002400050035 · Cited by 62
Primary pulmonary hypertension: Current therapy
Sitbon, O., Humbert, M. J. C., & Simonneau, G. (2002) · Progress in Cardiovascular Diseases · doi:10.1053/pcad.2002.128449 · Cited by 62
Dupuis, J., Jasmin, J., Prié, S., & Cernacek, P. (2000) · Pulmonary Pharmacology & Therapeutics · doi:10.1006/pupt.2000.0242 · Cited by 60
Pulmonary arterial hypertension and type-I glycogen-storage disease: the serotonin hypothesis
Humbert, M. J. C., Labrune, P., Sitbon, O., Gall, C., Callebert, J., Hervé, P., Samuel, D., Machado, R. D., Trembath, R. C., Drouet, L. O., et al. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.00258702 · Cited by 60
Pulmonary Haemodynamics at Rest and during Exercise in Patients with Sarcoidosis
Głuskowski, J., Hawryikłewicz, I., Zych, D., Wojtczak, A., & Zielinski, J. (2009) · Respiration · doi:10.1159/000194667 · Cited by 59
Abdul‐Salam, V. B., Paul, G. A., Ali, J. O., Gibbs, S. R., Rahman, D., Taylor, G. W., Wilkins, M. R., & Edwards, R. J. (2006) · PROTEOMICS · doi:10.1002/pmic.200500510 · Cited by 57
Hemodynamic unloading leads to regression of pulmonary vascular disease in rats
O’Blenes, S. B., Fischer, S., McIntyre, B. A. S., Keshavjee, S. H., & Rabinovitch, M. (2001) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1067/mtc.2001.111657 · Cited by 57
High Altitude Pulmonary Hypertension: Role of K + and Ca 2+ Channels
Remillard, C. V., & Yuan, J. X. ‐. (2005) · High Altitude Medicine & Biology · doi:10.1089/ham.2005.6.133 · Cited by 56
Jison, M. L., & Gladwin, M. T. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2304002 · Cited by 56
Heart-Lung Transplantation for Irreversible Pulmonary Hypertension
Jamieson, S. W., Stinson, E. B., Oyer, P. E., Reitz, B. A., Baldwin, J. C., Modry, D. L., Dawkins, K. D., Theodore, J., Hunt, S. A., & Shumway, N. E. (1984) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(10)62311-9 · Cited by 55
Molecular Basis of Cell-specific Endothelial Nitric-oxide Synthase Expression in Airway Epithelium
German, Z., Chambliss, K. L., Pace, M. C., Arnet, U. A., Lowenstein, C. J., & Shaul, P. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.11.8183 · Cited by 55
Pelouch, V., Kolář, F., Ošťádal, B., et al. (1997) · Cardiovascular Drugs and Therapy · doi:10.1023/a:1007788915732 · Cited by 54
Lessons learned from cancer may help in the treatment of pulmonary hypertension
Adnot, S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25399 · Cited by 54
Heart-lung transplantation for primary pulmonary hypertension
Whyte, R. I., Robbins, R. C., Altinger, J., Barlow, C. W., Doyle, R. L., Theodore, J., & Reitz, B. A. (1999) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(99)00176-9 · Cited by 54
Simvastatin enhances bone morphogenetic protein receptor type II expression
Hu, H., Sung, A. W., Zhao, G., Shi, L., Qiu, D., Nishimura, T., & Kao, P. N. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.10.187 · Cited by 54
A review of pulmonary arterial hypertension: role of ambrisentan.
Barst, R. J. (2007) · PubMed Central · Cited by 53
Regulation of pulmonary circulation by alveolar oxygen tension via airway nitric oxide
Ide, H., Nakano, H., Ogasa, T., Osanai, S., Kikuchi, K., & Iwamoto, J. (1999) · Journal of Applied Physiology · doi:10.1152/jappl.1999.87.5.1629 · Cited by 53
Thrombophilic factors in chronic thromboembolic pulmonary hypertension
Colorio, C. C., Martinuzzo, M. E., Forastiero, R. R., Pombo, G., Adamczuk, Y., & Carreras, L. O. (2001) · Blood Coagulation & Fibrinolysis · doi:10.1097/00001721-200109000-00002 · Cited by 53
Genetics and Mediators in Pulmonary Arterial Hypertension
Austin, E. D., & Loyd, J. E. (2007) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2006.11.007 · Cited by 53
Influence of panel-reactive antibody on survival and rejection after lung transplantation.
Gammie, J. S., Pham, S. M., Colson, Y. L., et al. (1997) · PubMed · Cited by 52
Pizzo, C. J. (1980) · PEDIATRICS · doi:10.1542/peds.65.2.341 · Cited by 52
Thomson, J., Machado, R. D., Pauciulo, M. W., Morgan, N. V., Yacoub, M. H., Corris, P. A., McNeil, K., Loyd, J. E., Nichols, W. C., & Trembath, R. C. (2001) · The Journal of Heart and Lung Transplantation · doi:10.1016/s1053-2498(01)00259-5 · Cited by 51
Nagaya, N., Okumura, H., Uematsu, M., Shimizu, W., Ono, F., Shirai, M., Mori, H., Miyatake, K., & Kangawa, K. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00548.2002 · Cited by 51
Dingemanse, J., Schaarschmidt, D., & van Giersbergen, P. L. M. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342030-00004 · Cited by 51
Nebulized nitric oxide/nucleophile adduct reduces chronic pulmonary hypertension.
Hampl, V., Tristani‐Firouzi, M., Hutsell, T. C., et al. (1996) · PubMed · Cited by 50
Diagnostik und Therapie der chronischen pulmonalen Hypertonie
Olschewski, H., Hoeper, M. M., Borst, M. M., Ewert, R., Grünig, E., Kleber, F. X., Kopp, B., Opitz, C. F., Reichenberger, F., Schmeißer, A., et al. (2006) · Pneumologie · doi:10.1055/s-2006-954981 · Cited by 50
THE PATHOLOGY OF PULMONARY ARTERY HYPERTENSION
Meyrick, B. O. (2001) · Clinics in Chest Medicine · doi:10.1016/s0272-5231(05)70279-3 · Cited by 47
Pulmonary hypertension in autoimmune rheumatic diseases: Where are we now?
Magliano, M., Isenberg, D. A., & Hillson, J. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10442 · Cited by 47
Changes in collagen metabolism in response to endothelin-1: Evidence for fibroblast heterogeneity
Dawes, K. E., Cambrey, A. D., Campa, J. S., Bishop, J. E., McAnulty, R. J., Peacock, A. J., & Laurent, G. J. (1996) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/1357-2725(95)00124-7 · Cited by 47
Karamanoglu, M., McGoon, M. D., Frantz, R. P., Benza, R. L., Bourge, R. C., Barst, R. J., Kjellström, B., & Bennett, T. (2007) · CHEST Journal · doi:10.1378/chest.06-2690 · Cited by 47
Self-citationPeacock, A. (2005) · Thorax · doi:10.1136/thx.2005.043216 · Cited by 46
Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease: A Case for Treatment
Higenbottam, T. (2005) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200411-053sf · Cited by 46
Clozel, M. (2003) · Annals of Medicine · doi:10.1080/07853890310017477 · Cited by 45
Connective tissue associated pulmonary arterial hypertension
Coghlan, G., & Handler, C. E. (2006) · Lupus · doi:10.1191/0961203306lu2280rr · Cited by 44
Franke, U. F. W., Wiebe, K., Harringer, W., Franke, T., Wittwer, T., Wahlers, T., & Haverich, A. (2000) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/s1010-7940(00)00525-x · Cited by 44
Boshier, A., Wilton, L., & Shakir, S. (2004) · British Journal of Urology · doi:10.1111/j.1464-410x.2003.04744.x · Cited by 44
Michelakis, E. D., Tymchak, W. J., Lien, D. C., DaSilva, L., Hashimoto, K., & Archer, S. L. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)80999-8 · Cited by 44
Knoop, C., Kentos, A., Remmelink, M., et al. (2006) · Clinical Transplantation · doi:10.1111/j.1399-0012.2005.00462.x · Cited by 43
Action of fenfluramine on voltage- gated K+ channels in human pulmonary-artery smooth-muscle cells
Wang, J., Juhaszova, M., Conte, J. V., Gaine, S., Rubin, L. J., & Yuan, J. X.-J. (1998) · The Lancet · doi:10.1016/s0140-6736(05)60264-4 · Cited by 43
Adrenomedullin in the treatment of pulmonary hypertension
Nagaya, N., & Kangawa, K. (2004) · Peptides · doi:10.1016/j.peptides.2004.07.007 · Cited by 43
THE ASSESSMENT OF PULMONARY HYPERTENSION
McGoon, M. D. (2001) · Clinics in Chest Medicine · doi:10.1016/s0272-5231(05)70286-0 · Cited by 43
Self-citationRight ventricular cardiac dysfunction in beta-thalassemia major.
Koren, A., Garty, I., Antonelli, D., et al. (1987) · PubMed · Cited by 42
The Pathology of the Arterial Pulmonary Vasculature in Manson's Schistosomiasis
Chaves, E. (1966) · Diseases of the Chest · doi:10.1016/s0096-0217(15)33023-5 · Cited by 42
Microangiopathic Hemolytic Anemia and Thrombocytopenia in Primary Pulmonary Hypertension
Stuard, I. D., Heusinkveld, R. S., & Moss, A. J. (1972) · New England Journal of Medicine · doi:10.1056/nejm197210262871710 · Cited by 41
Blanchard, D. G., & Dittrich, H. C. (1992) · Circulation · doi:10.1161/01.cir.85.4.1414 · Cited by 41
Effect of Dexfenfluramine Treatment in Rats Exposed to Acute and Chronic Hypoxia
Eddahibi, S., Raffestin, B., Launay, J., Sitbon, M., & Adnot, S. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.4.9704095 · Cited by 41
Medhora, M. M., Bousamra, M., Zhu, D., Somberg, L. B., & Jacobs, E. R. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00292.2001 · Cited by 41
Endothelin Receptor Antagonists in the Treatment of Pulmonary Arterial Hypertension
Langleben, D. (2007) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2006.11.002 · Cited by 40
5-Lipoxygenase and human pulmonary artery endothelial cell proliferation
Walker, J. L., Loscalzo, J., & Zhang, Y. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00003.2001 · Cited by 40
Moustapha, A., Kaushik, V., Diaz, S., Seung-Ho, K., & Barasch, E. (2001) · Cardiology · doi:10.1159/000047353 · Cited by 40
Pulmonary hypertension in polycythemia vera
Nand, S., & Orfei, E. (1994) · American Journal of Hematology · doi:10.1002/ajh.2830470320 · Cited by 38
The erbB/HER type 1 tyrosine kinase receptor family
Walker, R. A. (1998) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199807)185:3<313::aid-path93>3.0.co;2-8 · Cited by 38
Nonarteritic Anterior Ischemic Optic Neuropathy and Sildenafil
Fraunfelder, F. W., Pomeranz, H. D., & Egan, R. A. (2006) · Archives of Ophthalmology · doi:10.1001/archopht.124.5.733 · Cited by 38
Current Management of Primary Pulmonary Hypertension
Klings, E. S., & Farber, H. W. (2001) · Drugs · doi:10.2165/00003495-200161130-00005 · Cited by 38
McKenzie, J. C., Kelley, K. B., Merisko-Liversidge, E. M., Kennedy, J., & Klein, R. M. (1994) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1994.1090 · Cited by 37
Rabinovitch, M. (2001) · Journal of Clinical Investigation · doi:10.1172/jci14205 · Cited by 36
Pulmonary arterial hypertension after splenectomy for hereditary spherocytosis.
Smedema, J., & Louw, V. J. (2007) · PubMed · Cited by 36
Lung disease in systemic sclerosis (scleroderma)
Bolster, M. B., & Silver, R. M. (1993) · Baillière s Clinical Rheumatology · doi:10.1016/s0950-3579(05)80269-9 · Cited by 35
Barst, R. J. (2006) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.8.1.95 · Cited by 35
Söderman, C., Eriksson, L. S., JUHLIN‐DANNFELT, A., Lundberg, J. M., Broman, L. M., & Holmgren, A. (1993) · Clinical Physiology · doi:10.1111/j.1475-097x.1993.tb00482.x · Cited by 34
Prothrombotic mechanisms in primary pulmonary hypertension
Farber, H. W., & Loscalzo, J. (1999) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(99)90094-x · Cited by 34
Severe Pulmonary Hypertension Associated With Diastolic Left Ventricular Dysfunction
Willens, H. J., & Kessler, K. M. (1993) · CHEST Journal · doi:10.1378/chest.103.6.1877 · Cited by 33
Angiopoietin-1 and Pulmonary Hypertension: Cause or Cure?
Rudge, J. S., Thurston, G., & Yancopoulos, G. D. (2003) · Circulation Research · doi:10.1161/01.res.0000074031.94558.99 · Cited by 33
Bioactivity of adrenomedullin and proadrenomedullin N-terminal 20 peptide in man
Nicholls, M. G., Lainchbury, J. G., Lewis, L. K., et al. (2001) · Peptides · doi:10.1016/s0196-9781(01)00508-3 · Cited by 32
Combined therapy with zaprinast and inhaled nitric oxide abolishes hypoxic pulmonary hypertension
Nagamine, J., Hill, L. L., & Pearl, R. G. (2000) · Critical Care Medicine · doi:10.1097/00003246-200007000-00038 · Cited by 32
Short‐term Outcome and Predictors of Adverse Events following Pulmonary Thromboendarterectomy
Gilbert, T. B., Gaine, S., Rubin, L. J., & Sequeira, A. J. (1998) · World Journal of Surgery · doi:10.1007/s002689900511 · Cited by 30
Pulmonary hypertension in type I glycogen storage disease
Hamaoka, K., Nakagawa, M., Furukawa, N., & Sawada, T. (1990) · Pediatric Cardiology · doi:10.1007/bf02239550 · Cited by 30
Sack, K. E., & Criswell, L. A. (1992) · Southern Medical Journal · doi:10.1097/00007611-199209000-00005 · Cited by 25
Surrogate end points for pulmonary arterial hypertension
Kawut, S. M., & Palevsky, H. I. (2004) · American Heart Journal · doi:10.1016/j.ahj.2004.04.017 · Cited by 24
Primary pulmonary hypertension: the pressure rises for a gene
Thomson, J. R., & Trembath, R. C. (2000) · Journal of Clinical Pathology · doi:10.1136/jcp.53.12.899 · Cited by 24
Diastolic left ventricular dysfunction leading to severe reversible pulmonary hypertension
Kessler, K. M., Willens, H. J., & Mallon, S. M. (1993) · American Heart Journal · doi:10.1016/s0002-8703(07)80038-x · Cited by 21
Brief adrenomedullin inhalation leads to sustained reduction of pulmonary artery pressure
von der Hardt, K., Kandler, M., Chada, M., Cubra, A., Schoof, E., Amann, K., Rascher, W., & Dötsch, J. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00016103 · Cited by 20
Ambrisentan for Pulmonary Arterial Hypertension
Rubin, L. J., Dufton, C., & Gerber, M. J. (2005) · Future Cardiology · doi:10.2217/14796678.1.4.425 · Cited by 19
Dual ETA/ETBvs. selective ETAendothelin receptor antagonism in patients with pulmonary hypertension
Opitz, C. F., & Ewert, R. (2006) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2006.01691.x · Cited by 19
The Pathogenesis of HIV-Associated Pulmonary Hypertension
Klings, E. S., & Farber, H. W. (2003) · KARGER eBooks · doi:10.1159/000073176 · Cited by 17
McLaughlin, V. V., Oudiz, R. J., Frost, A., et al. (2005) · CHEST Journal · doi:10.1378/chest.128.4_meetingabstracts.160s · Cited by 13
Self-citationDynamics of Regression of Right Ventricular Hypertrophy in Rats with Hypoxic Pulmonary Hypertension
Kentera, D., & Sušić, D. (2009) · Respiration · doi:10.1159/000194227 · Cited by 12
Nangle, M. R., Cotter, M. A., & Cameron, N. E. (2003) · Nitric Oxide · doi:10.1016/j.niox.2004.01.006 · Cited by 12
[Pulmonary hypertension due to glycogen storage disease type II (Pompe's disease): a case report].
Inoue, S., Nakamura, T., Hasegawa, K., Tadaoka, S., Samukawa, M., Nezuo, S., Sawayama, T., Higashi, Y., & Shirabe, T. (1989) · PubMed · Cited by 9
Gender issues in pulmonary vascular disease
Robles, A. M., & Shure, D. (2004) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2004.01.007 · Cited by 6
Hoeper, M. M. (2007) · European Respiratory Journal · doi:10.1183/09031936.00001607 · Cited by 6
Cited by
Authors/Task Force Members, Galie, N., Hoeper, M. M., Humbert, M., Torbicki, A., Vachiery, J.-L., Barbera, J. A., Beghetti, M., Corris, P., Gaine, S., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp297 · Cited by 3,846
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
McLaughlin, V. V., Archer, S. L., Badesch, D. B., Barst, R. J., Farber, H. W., Lindner, J. R., Mathier, M. A., McGoon, M. D., Park, M. H., Rosenson, R. S., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.01.004 · Cited by 2,360
Self-citationChanges in causes of death in systemic sclerosis, 1972–2002
Steen, V. D., & Medsger, T. A. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.066068 · Cited by 1,528
Humbert, M., Sitbon, O., Chaouat, A., Bertocchi, M., Habib, G., Gressin, V., Yaïci, A., Weitzenblum, E., Cordier, J.-F., Chabot, F., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.911818 · Cited by 1,399
Guidelines for the diagnosis and treatment of pulmonary hypertension
(2009) · European Respiratory Journal · doi:10.1183/09031936.00139009 · Cited by 1,300
Metadata
- Authors
- McLaughlin, V. V., & McGoon, M. D.
- Venue
- Circulation
- Published
- 2006-09-26
- Volume
- 114
- Issue
- 13
- Pages
- 1417-1431
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2170331970
- Cited by
- 664
- References
- 800
- FWCI
- 39.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.